Bryan Banman

Bryan Banman is an accomplished leader in the biologics industry, currently serving as President & CEO of both CTM Biomedical and CTM Canada since July 2018. With a focus on advancing biologic solutions for clinical use, Bryan collaborates with top scientists and physicians to enhance the placental biologics market through innovative research and protocols. Previously, as SVP of Sales, Marketing & Business Development at Skye Orthobiologics from December 2011 to June 2018, Bryan successfully led national sales and market development initiatives. Additionally, Bryan's extensive consulting experience includes significant contributions to the development of groundbreaking biologic products and processing technologies at Human Regenerative Technologies and as a brand consultant at Common Sense. Bryan's career reflects a commitment to innovation in the fields of surgery, sports medicine, and regenerative medicine.